CG
RIGL icon

Cutler Group’s Rigel Pharmaceuticals RIGL Stock Holding History

Cutler Group’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-120
Closed -$1K – 3356
2023
Q4 		$1K Hold
120
– – ﹤0.01% 3419
2023
Q3 		$1K Hold
120
– – ﹤0.01% 3608
2023
Q2 		$1K Hold
120
– – ﹤0.01% 3382
2023
Q1 		$1K Hold
120
– – ﹤0.01% 3537
2022
Q4 		$1K Hold
120
– – ﹤0.01% 4137
2022
Q3 		$1K Hold
120
– – ﹤0.01% 4656
2022
Q2 		$1K Sell
120
-10
-8% -$201 ﹤0.01% 4699
2022
Q1 		$3K Buy
130
+10
+8% +$271 ﹤0.01% 4516
2021
Q4 		$3K Hold
120
– – ﹤0.01% 4564
2021
Q3 		$4K Sell
120
-150
-56% -$5.9K ﹤0.01% 4660
2021
Q2 		$11K Buy
270
+150
+125% +$5.66K ﹤0.01% 3832
2021
Q1 		$4K Sell
120
-766
-86% -$30.3K ﹤0.01% 4552
2020
Q4 		$31K Buy
886
+766
+638% +$22.2K ﹤0.01% 2342
2020
Q3 		$2K Buy
+120
New +$2.95K ﹤0.01% 4102
2019
Q2 		– Sell
-170
Closed -$4K – 4702
2019
Q1 		$4K Sell
170
-30
-15% -$686 ﹤0.01% 3067
2018
Q4 		$4K Hold
200
– – ﹤0.01% 3059
2018
Q3 		$6K Buy
+200
New +$6K ﹤0.01% 2961
2018
Q2 		– Sell
-530
Closed -$18K – 4751
2018
Q1 		$18K Buy
+530
New +$21.2K ﹤0.01% 2372
2017
Q1 		– Sell
-158
Closed -$3K – 7062
2016
Q4 		$3K Sell
158
-222
-58% -$6.36K ﹤0.01% 5374
2016
Q3 		$13K Buy
380
+370
+3,700% +$10.6K ﹤0.01% 3907
2016
Q2 		$0 Hold
10
– – ﹤0.01% 7175
2016
Q1 		$0 Buy
+10
New +$247 ﹤0.01% 7068

Other funds holding RIGL

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Cutler Group's RIGL Position: Q1 2024 in Review

Cutler Group sold out of Rigel Pharmaceuticals (RIGL) in Q1 2024, closing a stake of 120 shares — an estimated $1K sold.

Cutler Group first reported a position in RIGL in Q1 2016 and held it in 22 quarters. The position peaked at $31K in Q4 2020. 117 funds tracked by Wall St. Rank hold RIGL as of Q1 2024.

  • Cutler Group reported no remaining Rigel Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 120 Rigel Pharmaceuticals shares in Q1 2024, an estimated $1K.
  • Cutler Group first reported a position in Rigel Pharmaceuticals in Q1 2016 and held it in 22 quarters.
  • Cutler Group's Rigel Pharmaceuticals position peaked at $31K in Q4 2020.
  • 117 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.